198 related articles for article (PubMed ID: 34347220)
1. Survival Outcomes of Salvage Metastasectomy After Failure of Modern-Era Systemic Therapy for Melanoma.
Li AT; Vakharia K; Lo SN; Varey AHR; Carlino MS; Saw RPM; Shannon KF; Howle JR; Pennington TE; Stretch JR; Nieweg OE; Spillane AJ; Long GV; Menzies AM; Scolyer RA; Thompson JF; Ch'ng S
Ann Surg Oncol; 2021 Oct; 28(11):6109-6123. PubMed ID: 34347220
[TBL] [Abstract][Full Text] [Related]
2. Metastasectomy for melanoma is associated with improved overall survival in responders to targeted molecular or immunotherapy.
Medina BD; Choi BH; Rodogiannis KG; Moran U; Shapiro RL; Pavlick A; Osman I; Berman RS; Lee AY
J Surg Oncol; 2020 Sep; 122(3):555-561. PubMed ID: 32441371
[TBL] [Abstract][Full Text] [Related]
3. Metastasectomy Following Immunotherapy with Adoptive Cell Transfer for Patients with Advanced Melanoma.
Klemen ND; Feingold PL; Goff SL; Hughes MS; Kammula US; Yang JC; Schrump DS; Rosenberg SA; Sherry RM
Ann Surg Oncol; 2017 Jan; 24(1):135-141. PubMed ID: 27638681
[TBL] [Abstract][Full Text] [Related]
4. Use of immunotherapy and surgery for stage IV melanoma.
Molina G; Kasumova GG; Qadan M; Boland GM
Cancer; 2020 Jun; 126(11):2614-2624. PubMed ID: 32157676
[TBL] [Abstract][Full Text] [Related]
5. Impact of Effective Systemic Therapy on Metastasectomy in Stage IV Melanoma: A Matched-Pair Analysis.
Nelson DW; Fischer TD; Graff-Baker AN; Dehal A; Stern S; Bilchik AJ; Faries MB
Ann Surg Oncol; 2019 Dec; 26(13):4610-4618. PubMed ID: 31183639
[TBL] [Abstract][Full Text] [Related]
6. Patterns of failure after immunotherapy with checkpoint inhibitors predict durable progression-free survival after local therapy for metastatic melanoma.
Klemen ND; Wang M; Feingold PL; Cooper K; Pavri SN; Han D; Detterbeck FC; Boffa DJ; Khan SA; Olino K; Clune J; Ariyan S; Salem RR; Weiss SA; Kluger HM; Sznol M; Cha C
J Immunother Cancer; 2019 Jul; 7(1):196. PubMed ID: 31340861
[TBL] [Abstract][Full Text] [Related]
7. Survival Outcomes After Metastasectomy in Melanoma Patients Categorized by Response to Checkpoint Blockade.
Bello DM; Panageas KS; Hollmann T; Shoushtari AN; Momtaz P; Chapman PB; Postow MA; Callahan MK; Wolchok JD; Brady MS; Coit DG; Ariyan CE
Ann Surg Oncol; 2020 Apr; 27(4):1180-1188. PubMed ID: 31848819
[TBL] [Abstract][Full Text] [Related]
8. Thoracic Metastasectomy in Germ Cell Tumor Patients Treated With First-line Versus Salvage Therapy.
Caso R; Jones GD; Tan KS; Bosl GJ; Funt SA; Sheinfeld J; Reuter VE; Amar D; Fischer G; Molena D; Rocco G; Bains MS; Feldman DR; Jones DR
Ann Thorac Surg; 2021 Apr; 111(4):1141-1149. PubMed ID: 32882201
[TBL] [Abstract][Full Text] [Related]
9. Metastasectomy for metastatic melanoma in the era of effective systemic therapy.
Schwantes IR; Sutton T; Behrens S; Fowler G; Han G; Vetto JT; Han D
Am J Surg; 2024 May; 231():65-69. PubMed ID: 37308347
[TBL] [Abstract][Full Text] [Related]
10. Metastatic melanoma to small bowel: metastasectomy is supported in the era of immunotherapy and checkpoint inhibitors.
Wong P; Wisneski AD; Tsai KK; Chang TT; Hirose K; Nakakura EK; Daud AI; Maker AV; Corvera CU
World J Surg Oncol; 2024 Mar; 22(1):77. PubMed ID: 38468341
[TBL] [Abstract][Full Text] [Related]
11. Prolonged overall survival following metastasectomy in stage IV melanoma.
Elias ML; Behbahani S; Maddukuri S; John AM; Schwartz RA; Lambert WC
J Eur Acad Dermatol Venereol; 2019 Sep; 33(9):1719-1725. PubMed ID: 31070816
[TBL] [Abstract][Full Text] [Related]
12. Post-operative survival following metastasectomy for patients receiving BRAF inhibitor therapy is associated with duration of pre-operative treatment and elective indication.
He M; Lovell J; Ng BL; Spillane J; Speakman D; Henderson MA; Shackleton M; Gyorki DE
J Surg Oncol; 2015 Jun; 111(8):980-4. PubMed ID: 26080731
[TBL] [Abstract][Full Text] [Related]
13. Association of Surgical Treatment, Systemic Therapy, and Survival in Patients With Abdominal Visceral Melanoma Metastases, 1965-2014: Relevance of Surgical Cure in the Era of Modern Systemic Therapy.
Deutsch GB; Flaherty DC; Kirchoff DD; Bailey M; Vitug S; Foshag LJ; Faries MB; Bilchik AJ
JAMA Surg; 2017 Jul; 152(7):672-678. PubMed ID: 28384791
[TBL] [Abstract][Full Text] [Related]
14. The combination of stereotactic radiosurgery with immune checkpoint inhibition or targeted therapy in melanoma patients with brain metastases: a retrospective study.
Martins F; Schiappacasse L; Levivier M; Tuleasca C; Cuendet MA; Aedo-Lopez V; Gautron Moura B; Homicsko K; Bettini A; Berthod G; Gérard CL; Wicky A; Bourhis J; Michielin O
J Neurooncol; 2020 Jan; 146(1):181-193. PubMed ID: 31836957
[TBL] [Abstract][Full Text] [Related]
15. Improvement of overall survival in stage IV melanoma patients during 2011-2014: analysis of real-world data in 441 patients of the German Central Malignant Melanoma Registry (CMMR).
Forschner A; Eichner F; Amaral T; Keim U; Garbe C; Eigentler TK
J Cancer Res Clin Oncol; 2017 Mar; 143(3):533-540. PubMed ID: 27878363
[TBL] [Abstract][Full Text] [Related]
16. The value of metastasectomy in stage IV cutaneous melanoma.
Wollina U; Brzezinski P
Wien Med Wochenschr; 2019 Oct; 169(13-14):331-338. PubMed ID: 29511905
[TBL] [Abstract][Full Text] [Related]
17. Long-Term Survival of De Novo Stage IV Human Epidermal Growth Receptor 2 (HER2) Positive Breast Cancers Treated with HER2-Targeted Therapy.
Wong Y; Raghavendra AS; Hatzis C; Irizarry JP; Vega T; Horowitz N; Barcenas CH; Chavez-MacGregor M; Valero V; Tripathy D; Pusztai L; Murthy RK
Oncologist; 2019 Mar; 24(3):313-318. PubMed ID: 30139836
[TBL] [Abstract][Full Text] [Related]
18. Metastasectomy for stage IV melanoma.
Deutsch GB; Kirchoff DD; Faries MB
Surg Oncol Clin N Am; 2015 Apr; 24(2):279-98. PubMed ID: 25769712
[TBL] [Abstract][Full Text] [Related]
19. Association of Survival and Immune-Related Biomarkers With Immunotherapy in Patients With Non-Small Cell Lung Cancer: A Meta-analysis and Individual Patient-Level Analysis.
Yu Y; Zeng D; Ou Q; Liu S; Li A; Chen Y; Lin D; Gao Q; Zhou H; Liao W; Yao H
JAMA Netw Open; 2019 Jul; 2(7):e196879. PubMed ID: 31290993
[TBL] [Abstract][Full Text] [Related]
20. Role of Surgery in Stage IV Melanoma.
O'Neill CH; McMasters KM; Egger ME
Surg Oncol Clin N Am; 2020 Jul; 29(3):485-495. PubMed ID: 32482322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]